9997 — Kangji Medical Holdings Income Statement
0.000.00%
Last trade - 00:00
- HK$7.96bn
- HK$5.41bn
- CNY926.02m
- 86
- 55
- 49
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 503 | 511 | 690 | 786 | 926 |
Cost of Revenue | |||||
Gross Profit | 423 | 431 | 563 | 635 | 741 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 112 | 201 | 156 | 221 | 335 |
Operating Profit | 391 | 310 | 535 | 565 | 591 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 391 | 310 | 534 | 563 | 589 |
Provision for Income Taxes | |||||
Net Income After Taxes | 327 | 259 | 457 | 461 | 452 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 206 | 250 | 457 | 479 | 504 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 206 | 250 | 457 | 479 | 504 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.201 | 0.288 | 0.371 | 0.396 | 0.431 |
Dividends per Share |